Show simple item record

dc.contributor.authorPrasad, V
dc.contributor.authorSrirajaskanthan, R
dc.contributor.authorGrana, CM
dc.contributor.authorBaldari, S
dc.contributor.authorShah, T
dc.contributor.authorLamarca, Angela
dc.contributor.authorCourbon, F
dc.contributor.authorScheidhauer, K
dc.contributor.authorBaudin, E
dc.contributor.authorTruong-Thanh, XM
dc.contributor.authorHouchard, A
dc.contributor.authorBodei, L
dc.date.accessioned2019-04-29T09:48:53Z
dc.date.available2019-04-29T09:48:53Z
dc.date.issued2018en
dc.identifier.citationPrasad V, Srirajaskanthan R, Grana CM, Baldari S, Shah T, Lamarca A, et al. 1331P Tumour growth rate (TGR) when using lanreotide Autogel� (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs). Annals of Oncology. 2018;29(suppl_8).en
dc.identifier.pmidNo PMIDen
dc.identifier.doi10.1093/annonc/mdy293.024en
dc.identifier.urihttp://hdl.handle.net/10541/621729
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdy293.024en
dc.titleTumour growth rate (TGR) when using lanreotide Autogel (R) (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Nuclear Medicine, Universitaetsfrauenklinik Ulm, Ulm, Germanyen
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]
refterms.dateFOA2020-04-20T12:18:16Z


Files in this item

Thumbnail
Name:
561581.pdf
Size:
107.5Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record